CAS 952652-79-8

Formula: C23H27N5O3

InChI: InChI=1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1

InChI key: OKAQHVJSXLGXET-NRFANRHFSA-N

SMILES: CCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O

Valsartan Related Compound B

CAS: 952652-79-8

Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi

Formula: C₂₃H₂₇N₅O₃

Colore e forma: White Powder

Peso molecolare: 421.21139

Ref: 45-1708784

(S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

CAS: 952652-79-8

(S)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

Formula: C₂₃H₂₇N₅O₃

Purezza: 95%

Peso molecolare: 421.49

Ref: 54-OR1124846

Valsartan EP Impurity C (Valsartan USP Related Compound B)

CAS: 952652-79-8

Formula: C₂₃H₂₇N₅O₃

Colore e forma: Off-White Solid

Peso molecolare: 421.50

Ref: 4Z-V-026

(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

CAS: 952652-79-8

Formula: C₂₃H₂₇N₅O₃

Purezza: 95%

Colore e forma: Solid

Peso molecolare: 421.4922

Ref: IN-DA00IIWL

(2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic Acid

CAS: 952652-79-8

Formula: C₂₃H₂₇N₅O₃

Colore e forma: Neat

Peso molecolare: 421.49

Ref: 86-MM0487.04

Valsartan n-Propyl Impurity

Prodotto controllato

CAS: 952652-79-8

Impurity Valsartan Related Compound B
Applications Valsartan n-Propyl is an impurity in the synthesis of Valsartan (V095750). Valsartan USP Related Compound B.
References Hillaert, S., et al.: J. Pharm. Biomed. Anal., 31, 329 (2003), Carlucci, G., et al.: Anal. Lett., 33, 2491 (2000), Cagigal, E., et al.: Talanta, 54, 1121 (2001),

Formula: C₂₃H₂₇N₅O₃

Colore e forma: Neat

Peso molecolare: 421.49

Ref: TR-V095770

Valsartan Impurity 46

CAS: 952652-79-8

Formula: C₂₅H₃₁N₅O₃

Colore e forma: Off-White Solid

Peso molecolare: 449.56

Ref: 4Z-V-0268

Valsartan EP Impurity C

CAS: 952652-79-8

Formula: C₂₃H₂₇N₅O₃

Peso molecolare: 421.49

Ref: ST-EA-CP-V3003

(S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine

CAS: 952652-79-8

(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid

Formula: C₂₃H₂₇N₅O₃

Purezza: 98%

Peso molecolare: 421.49

Ref: IN-DG164353

N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine

CAS: 952652-79-8

N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine (GW1929) is a potent vasodilator that is used for the treatment of hypertension. It is synthesized by condensation of sodium hydroxide with 2-(4′-chlorophenyl)piperazine followed by methyl esterification and chloride acylation. The synthesis of GW1929 has been accomplished in two steps: carbonate cyclization and valsartan hydrolysis. In the first step, the carboxylic acid group of GW1929 was converted to its corresponding chloride compound which was then reacted with methyl bromide to yield the desired product. The second step involved hydrolysis of GW1929 with potassium carbonate, after which it was oxidized with azide to form an ester. Sodium

Formula: C₂₃H₂₇N₅O₃

Purezza: Min. 95%

Colore e forma: White Powder

Peso molecolare: 421.49 g/mol

Ref: 3D-IO28664